By the end of 2023, the global Prophy Dental Handpiece Market is anticipated to have a value of US$ 229.3 million, and it will grow at a CAGR of 5.7% to reach US$ 398.8 million by the year 2033. Electric-driven prophy dental handpieces are anticipated to hold the majority of the market in 2023, with …
Category Archives: Healthcare Trends
Generalized Anxiety Disorder Treatment Market is on the upswing, set to grow at a 9% CAGR by 2033 | FMI
The generalized anxiety disorder treatment market is projected to reach a market size of US$ 1800 million in 2023 and US$ 4261.25 million by 2033, growing at a CAGR of 9% over that time. The market for treating generalised anxiety disorder is expanding due to the rising incidence of mental health issues and the wide …
Salivary Gland Infection Treatment Market is poised to hit US$ 12,300 Million in value by 2033, according to a study by FMI
The Salivary Gland Infection Treatment Market is anticipated to reach a market size of US$ 5054.79 million in 2023 and US$ 12,300 million by 2033, with a CAGR of 9.3%. The rising incidence of salivary gland infections and the accessibility of pharmaceuticals to treat the condition are both factors contributing to the growth of the …
Sandhoff Disease Therapeutics Market is estimated to exhibit a 6% CAGR, bringing its value to US$ 17.91 Million by 2033, according to FMI
According to a recent study published by Future Market Insights, the sandhoff disease therapeutics market is slated to experience noteworthy expansion. The market for Sandhoff disease therapeutics is forecast to accumulate a market value of US$ 10 million by 2023-end, and will ultimately reach a valuation of US$ 17.91 million by 2033. Registering a CAGR …
Brain Tumor Drugs Market is advancing steadily and is expected to reach US$ 6.30 Billion by 2033 | FMI
The market for pharmaceuticals used to treat brain tumors is known as the ” Brain Tumor Drugs Market,” and it is a subset of the pharmaceutical business. Brain tumors are abnormal cell growths in the brain that may or may not be cancerous (benign) or malignant (cancerous). They can have a variety of symptoms and …
Low-Grade Glioma Therapeutics Market is poised to attain a value of US$ 1515.47 Million by 2033 | FMI
The global low-grade glioma therapeutics market is expected to grow from US$ 1038 Million in 2023 to US$ 1515.47 Million by 2033, at a CAGR of 4.57% during the forecast period. The growth of the market is attributed to the increasing prevalence of low-grade glioma and the rising demand for effective and innovative treatments. Low-grade …
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is expected to record a steady 6% CAGR over the period 2023 to 2033, as per the FMI report
During the forecast period 2023 to 2033, the Gastrointestinal stromal tumor (GIST) therapeutics market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Gastrointestinal stromal tumor (GIST) therapeutics is expected to rise up to a market valuation of US$ 1593 Million. …
Epidemic Keratoconjunctivitis Treatment Market is experiencing a steady growth with a CAGR of 5% during the period from 2023 to 2033
The global epidemic keratoconjunctivitis treatment market is anticipated to reach a market size of US$ 500 million in 2023 and US$ 814.45 million by exhibiting a CAGR of 5% from 2023 to 2033. From 2018 to 2022, the market for treating epidemic keratoconjunctivitis experienced a 4% CAGR. The successful management of epidemic keratoconjunctivitis is the …
Kyphoscoliosis Treatment Market Projects a 5% CAGR Growth from 2023 to 2033-FMI Projection
In the upcoming years, there is anticipated to be a significant increase in the global kyphoscoliosis treatments market due to factors like rising healthcare costs, increasing awareness of spinal disorders, increasing prevalence of kyphoscoliosis, and advancements in treatment options. According to a new market research report published by Future Market insights, the global kyphoscoliosis treatment …
Developmental and Epileptic Encephalopathies (DEE) Treatment Market Aims for US$ 11.4 Billion Valuation by 2033 -FMI Projection
The global Developmental and Epileptic Encephalopathies (DEE) Treatment Market is expected to generate a market value of US$ 7 billion in 2023 and a market value of US$ 11.4 billion by 2033, with a CAGR of 5% from 2023 to 2033. The market for Developmental and Epileptic Encephalopathies (DEE) Treatment grew at a 3.5% CAGR from 2018 …